A US health official reported Friday, from a high of 48 just two weeks ago, there has been a decline in the number of states reporting widespread swine flu activity to just 25 this week.

Meanwhile, Dr. Thomas R. Frieden, Director of the U. S. Centres for Disease Control and Prevention reporting during an afternoon press conference said, the supply of H1N1 swine flu vaccine continues to increase, with 73-million H1N1 vaccine doses available, as of today, twice that of a month ago, 10-million more than last week, and another 10-million expected in the coming week.

Children, women who are pregnant, young adults, people working in the health-care industry, people taking care of infants, including adults suffering from underlying health problems, such as, asthma and diabetes remaining at the top of the list for vaccination.

According to Frieden, all the data on vaccine safety is reassuring, so far, with Guillain-Barre syndrome rates that apparently increased in response to 1976’s swine flu vaccine remaining unchanged with this year’s vaccine.

Guillain-Barre syndrome is a disorder, wherein the body’s immune system mistakenly attacks the peripheral nervous system.

Swine flu this year continues to target children and young adults, with an additional 17-cases of children dying from influenza documented this week, bringing the total of confirmed deaths among children to 210.

According to the U. S. Centres for Disease Control and Prevention, swine flu rates have been declining for the fifth straight week, with the lowest number of reported hospitalizations and deaths in over two months.